340 related articles for article (PubMed ID: 28753077)
1. Low dose cyclosporine A in the treatment of resistant proliferative lupus nephritis.
Sheikholeslami M; Hajialilo M; Rasi Hashemi SS; Malek Mahdavi A; Gojazadeh M; Khabbazi A
Mod Rheumatol; 2018 May; 28(3):523-529. PubMed ID: 28753077
[TBL] [Abstract][Full Text] [Related]
2. Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis.
Jesus D; Rodrigues M; da Silva JAP; Inês L
Lupus; 2018 Jul; 27(8):1358-1362. PubMed ID: 29448882
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis.
Aragon E; Resontoc LP; Chan YH; Lau YW; Tan PH; Loh HL; Ng KH; Yap HK
Lupus; 2016 Apr; 25(4):399-406. PubMed ID: 26537422
[TBL] [Abstract][Full Text] [Related]
4. Good outcomes with mycophenolate-cyclosporine-based induction protocol in children with severe proliferative lupus nephritis.
Aragon E; Chan YH; Ng KH; Lau YW; Tan PH; Yap HK
Lupus; 2010 Jul; 19(8):965-73. PubMed ID: 20581019
[TBL] [Abstract][Full Text] [Related]
5. Low-dose cyclosporine for active lupus nephritis: a dose titration approach.
Sumethkul K; Kitumnuaypong T; Angthararak S; Pichaiwong W
Clin Rheumatol; 2019 Aug; 38(8):2151-2159. PubMed ID: 30937637
[TBL] [Abstract][Full Text] [Related]
6. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
[TBL] [Abstract][Full Text] [Related]
7. Remission and long-term outcomes of proliferative lupus nephritis: retrospective study of 96 patients from Saudi Arabia.
Almalki AH; Alrowaie FA; Alhozali HM; Almalki NK; Alsubei AI; Alturki MS; Sadagah LF
Lupus; 2019 Aug; 28(9):1082-1090. PubMed ID: 31296138
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus.
Yang TH; Wu TH; Chang YL; Liao HT; Hsu CC; Tsai CY; Chou YC
Clin Nephrol; 2018 Apr; 89(4):277-285. PubMed ID: 29319493
[TBL] [Abstract][Full Text] [Related]
9. Effect of low-dose cyclosporine A in the treatment of refractory proteinuria in childhood-onset lupus nephritis.
Baca V; Catalán T; Villasís-Keever M; Ramón G; Morales AM; Rodríguez-Leyva F
Lupus; 2006; 15(8):490-5. PubMed ID: 16942000
[TBL] [Abstract][Full Text] [Related]
10. Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy.
Mao Y; Yin L; Huang H; Zhou Z; Chen T; Zhou W
J Int Med Res; 2019 Jan; 47(1):105-113. PubMed ID: 30208769
[TBL] [Abstract][Full Text] [Related]
11. Comparative clinical prospective therapeutic study between cyclophosphamide, cyclosporine and azathioprine in the treatment of lupus nephritis.
El-Sehemy MS; Al-Saaran AM; Baddour NM; Adam AG; Moez PE
Egypt J Immunol; 2006; 13(1):39-52. PubMed ID: 17974149
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
Choi CB; Won S; Bae SC
Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
[TBL] [Abstract][Full Text] [Related]
13. Response to combination of mycophenolate mofetil, cyclosporin A and corticosteroid treatment in lupus nephritis patients with persistent proteinuria.
Kasitanon N; Boripatkosol P; Louthrenoo W
Int J Rheum Dis; 2018 Jan; 21(1):200-207. PubMed ID: 28901731
[TBL] [Abstract][Full Text] [Related]
14. Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis.
Kamijo Y; Hashimoto K; Takahashi K; Ehara T; Shigematsu H; Higuchi M
Clin Nephrol; 2011 Aug; 76(2):136-43. PubMed ID: 21762646
[TBL] [Abstract][Full Text] [Related]
15. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
F L; Y T; X P; L W; H W; Z S; H Z; Z H;
Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice.
Ogawa H; Kameda H; Amano K; Takeuchi T
Lupus; 2010 Feb; 19(2):162-9. PubMed ID: 19952069
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group.
Chan TM; Li FK; Tang CS; Wong RW; Fang GX; Ji YL; Lau CS; Wong AK; Tong MK; Chan KW; Lai KN
N Engl J Med; 2000 Oct; 343(16):1156-62. PubMed ID: 11036121
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.
Weng MY; Weng CT; Liu MF
Clin Rheumatol; 2010 Jul; 29(7):771-5. PubMed ID: 20195879
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
[TBL] [Abstract][Full Text] [Related]
20. Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis.
Mok CC
Nephrol Dial Transplant; 2016 Oct; 31(10):1561-6. PubMed ID: 27591327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
